Huang HJ, Neven P, Drijkoningen M, Paridaens R, Wildiers H, Van Limbergen E, et al. Association between tumour characteristics and HER-2/neu by immunohistochemistry in 1362 women with primary operable breast cancer. J Clin Pathol. 2005;58:611–6. https://doi.org/10.1136/jcp.2004.022772.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ma H, Lu Y, Marchbanks PA, Folger SG, Strom BL, McDonald JA, et al. Quantitative measures of estrogen receptor expression in relation to breast cancer-specific mortality risk among white women and black women. Breast Cancer Res. 2013;15:R90. https://doi.org/10.1186/bcr3486.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Burstein HJ, Lacchetti C, Anderson H, Buchholz TA, Davidson NE, Gelmon KA, et al. Adjuvant endocrine therapy for women with hormone receptor–positive breast cancer: ASCO clinical practice guideline focused update. J Clin Oncol. 2019;37:423–38. https://doi.org/10.1200/JCO.18.01160.

Article  CAS  PubMed  Google Scholar 

Early Breast Cancer Trialists’ Collaborative Group (EBCTCG), Davies C, Godwin J, Gray R, Clarke M, Cutter D, et al. Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. Lancet. 2011;378:771–84. https://doi.org/10.1016/s0140-6736(11)60993-8.

Article  Google Scholar 

Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials. Lancet. 2015;386:1341–52. https://doi.org/10.1016/s0140-6736(15)61074-1.

Article  Google Scholar 

Vrijens B, De Geest S, Hughes DA, Przemyslaw K, Demonceau J, Ruppar T, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73:691–705. https://doi.org/10.1111/j.1365-2125.2012.04167.x.

Article  PubMed  PubMed Central  Google Scholar 

Huiart L, Ferdynus C, Giorgi R. A meta-regression analysis of the available data on adherence to adjuvant hormonal therapy in breast cancer: summarizing the data for clinicians. Breast Cancer Res Treat. 2013;138:325–8. https://doi.org/10.1007/s10549-013-2422-4.

Article  PubMed  Google Scholar 

Murphy CC, Bartholomew LK, Carpentier MY, Bluethmann SM, Vernon SW. Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review. Breast Cancer Res Treat. 2012;134:459–78. https://doi.org/10.1007/s10549-012-2114-5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lailler G, Memoli V, Le Bihan BC, Ben Diane MK, Lauzier S, Mancini J, et al. Five-year adjuvant endocrine therapy adherence trajectories among women with breast cancer: a nationwide French study using administrative data. Clin Breast Cancer. 2021;21:e415–26. https://doi.org/10.1016/j.clbc.2021.01.007.

Article  CAS  PubMed  Google Scholar 

Lambert-Côté L, Bouhnik A-D, Bendiane M-K, Bérenger C, Mondor M, Huiart L, et al. Adherence trajectories of adjuvant endocrine therapy in the five years after its initiation among women with non-metastatic breast cancer: a cohort study using administrative databases. Breast Cancer Res Treat. 2020;180:777–90.

Article  PubMed  Google Scholar 

Winn AN, Dusetzina SB. The association between trajectories of endocrine therapy adherence and mortality among women with breast cancer. Pharmacoepidemiol Drug Saf. 2016;25:953–9. https://doi.org/10.1002/pds.4012.

Article  CAS  PubMed  Google Scholar 

Tervonen HE, Daniels B, Tang M, Preen DB, Pearson SA. Patterns of endocrine therapy in a national cohort of early stage HER2-positive breast cancer patients. Pharmacoepidemiol Drug Saf. 2019;28:812–20.

Article  CAS  PubMed  Google Scholar 

Inotai A, Agh T, Maris R, Erdosi D, Kovacs S, Kalo Z, et al. Systematic review of real-world studies evaluating the impact of medication non-adherence to endocrine therapies on hard clinical endpoints in patients with non-metastatic breast cancer. Cancer Treat Rev. 2021;100:102264. https://doi.org/10.1016/j.ctrv.2021.102264.

Article  CAS  PubMed  Google Scholar 

Eliassen FM, Blåfjelldal V, Helland T, Hjorth CF, Hølland K, Lode L, et al. Importance of endocrine treatment adherence and persistence in breast cancer survivorship: a systematic review. BMC Cancer. 2023;23:625. https://doi.org/10.1186/s12885-023-11122-8.

Article  PubMed  PubMed Central  Google Scholar 

Lambert LK, Balneaves LG, Howard AF, Gotay CC. Patient-reported factors associated with adherence to adjuvant endocrine therapy after breast cancer: an integrative review. Breast Cancer Res Treat. 2018;167:615–33. https://doi.org/10.1007/s10549-017-4561-5.

Article  PubMed  Google Scholar 

Paranjpe R, John G, Trivedi M, Abughosh S. Identifying adherence barriers to oral endocrine therapy among breast cancer survivors. Breast Cancer Res Treat. 2019;174:297–305. https://doi.org/10.1007/s10549-018-05073-z.

Article  PubMed  Google Scholar 

Toivonen KI, Williamson TM, Carlson LE, Walker LM, Campbell TS. Potentially modifiable factors associated with adherence to adjuvant endocrine therapy among breast cancer survivors: a systematic review. Cancers (Basel). 2020;13:107. https://doi.org/10.3390/cancers13010107.

Article  PubMed  PubMed Central  Google Scholar 

Moon Z, Moss-Morris R, Hunter MS, Carlisle S, Hughes LD. Barriers and facilitators of adjuvant hormone therapy adherence and persistence in women with breast cancer: a systematic review. Patient Prefer Adherence. 2017;11:305–22.

Article  PubMed  PubMed Central  Google Scholar 

Yussof I, Mohd Tahir NA, Hatah E, Mohamed SN. Factors influencing five-year adherence to adjuvant endocrine therapy in breast cancer patients: a systematic review. Breast. 2022;62:22–35. https://doi.org/10.1016/j.breast.2022.01.012.

Article  PubMed  PubMed Central  Google Scholar 

Xu H, Zhang XJ, Wang DQ, Xu L, Wang AP. Factors influencing medication-taking behaviour with adjuvant endocrine therapy in women with breast cancer: a qualitative systematic review. J Adv Nurs. 2020;76:445–58. https://doi.org/10.1111/jan.14253.

Article  PubMed  Google Scholar 

Peddie N, Agnew S, Crawford M, Dixon D, MacPherson I, Fleming L. The impact of medication side effects on adherence and persistence to hormone therapy in breast cancer survivors: a qualitative systematic review and thematic synthesis. Breast. 2021;58:147–59. https://doi.org/10.1016/j.breast.2021.05.005.

Article  PubMed  PubMed Central  Google Scholar 

Bright EE, Finkelstein LB, Nealis MS, Genung SR, Wrigley J, Gu HCJ, et al. A systematic review and meta-analysis of interventions to promote adjuvant endocrine therapy adherence among breast cancer survivors. J Clin Oncol. 2023;41:4548–61. https://doi.org/10.1200/jco.23.00697.

Article  CAS  PubMed  Google Scholar 

Skivington K, Matthews L, Simpson SA, Craig P, Baird J, Blazeby JM, et al. A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance. BMJ. 2021;374:n2061. https://doi.org/10.1136/bmj.n2061.

Article  PubMed  PubMed Central  Google Scholar 

Webb TL, Sheeran P. Does changing behavioral intentions engender behavior change? A meta-analysis of the experimental evidence. Psychol Bull. 2006;132:249–68. https://doi.org/10.1037/0033-2909.132.2.249.

Article  PubMed  Google Scholar 

Turcotte V, Guillaumie L, Lemay M, Dionne A, Lemieux J, Provencher L, Lauzier S. The perspective of breast cancer women participating in an adherence-enhancing program for adjuvant endocrine therapy. Abstracts of the 25th Annual Meeting of ESPACOMP, the international society for medication adherence. Int J Clin Pharm. 2022;44:281. https://doi.org/10.1007/s11096-021-01373-5.

Article  Google Scholar 

Bartholomew L, Parcel G, Kok G, Gottlieb N, Fernandez M. Planning health promotion programs: an intervention mapping approach Jossey-Bass. 3rd ed. ed. Hoboken, N.J., US: Jossey-Bass/Wiley; 2011.

Ajzen I. The theory of planned behavior. Organ Behav Hum Decis Process. 1991;50:179–211. https://doi.org/10.1016/0749-5978(91)90020-T.

Article  Google Scholar 

Fishbein M, Ajzen I. Predicting and changing behavior: the reasoned action approach. New York, US: Taylor & Francis; 2011.

Book  Google Scholar 

Humphries B, Collins S, Guillaumie L, Lemieux J, Dionne A, Provencher L, et al. Women’s beliefs on early adherence to adjuvant endocrine therapy for breast cancer: a theory-based qualitative study to guide the development of community pharmacist interventions. Pharmacy (Basel, Switzerland). 2018;6:53. https://doi.org/10.3390/pharmacy6020053.

Article  PubMed  Google Scholar 

Gagne M, Lauzier S, Lemay M, Loiselle CG, Provencher L, Simard C, et al. Women with breast cancer’s perceptions of nurse-led telephone-based motivational interviewing consultations to enhance adherence to adjuvant endocrine therapy: a qualitative study. Support Care Cancer. 2022;30:4759–68. https://doi.org/10.1007/s00520-021-06692-x.

Article  PubMed  PubMed Central  Google Scholar 

Stephen J, Rojubally A, Macgregor K, McLeod D, Speca M, Taylor-Brown J, et al. Evaluation of CancerChatCanada: a program of online support for Canadians affected by cancer. Curr Oncol. 2013;20:39–47. https://doi.org/10.3747/co.20.1210.

Article  CAS  PubMed  PubMed Central  Google Scholar 

La Gagné C. mesure des variables théoriques et des comportements. In: Godin G, editor. Les comportements dans le domaine de la santé: Comprendre pour mieux intervenir. Montréal, CA: Les Presses de l’Université de Montréal; 2012. p. 231–92.

Google Scholar 

Grégoire J, Moisan J. Assessment of adherence to drug treatment in database research. In: Elseviers Mea, editor. Drug utilization research: methods and applications. First ed: Wiley & Sons, Ltd.; 2016;369–80.

Morris SB. Estimating effect sizes from pretest-posttest-control group designs. Organ Res Methods. 2008;11:364–86. https://doi.org/10.1177/1094428106291059.

Article  Google Scholar 

En-Nasery-de Heer S, Tromp V, Westerman MJ, Konings I, Beckeringh JJ, Boons CLM, et al. Patient experiences and views on pharmaceutical care during adjuvant endocrine therapy for breast cancer: a qualitative study. Eur J Cancer Care (Engl). 2022;31:e13749. https://doi.org/10.1111/ecc.13749.

Article  PubMed  Google Scholar 

Milata JL, Otte JL, Carpenter JS. Oral endocrine therapy nonadherence, adverse effects, decisional support, and decisional needs in women with breast cancer. Cancer Nurs. 2018;41:E9–18. https://doi.org/10.1097/ncc.0000000000000430.

Article  PubMed